WeVote
Log In

Bill

Bill

HB 2366

Revenue and taxation; income tax credit; biomanufacturing; effective date.

2026 Regular Session Introduced by Mark Tedford

Oklahoma bill creates income tax credit for biomanufacturing companies to attract and retain biological product manufacturing businesses in the state.

Referred to Rules
0
WeVote Research Nonpartisan
Bill Summary · HB 2366

Legislative bill overview

HB 2366 creates an income tax credit for businesses engaged in biomanufacturing activities in Oklahoma. The bill aims to incentivize the development and expansion of the biomanufacturing sector within the state by offering tax relief to qualifying companies.

Why is this important

Biomanufacturing—the production of biological products like pharmaceuticals, vaccines, and biologics—represents a high-value industry that states compete to attract. Tax incentives can influence business location and expansion decisions, potentially creating jobs and diversifying Oklahoma's economy beyond traditional sectors.

Potential points of contention

  • Fiscal impact and cost: The state revenue loss from the tax credit is not specified in available information, making it unclear whether the benefit justifies the foregone tax revenue
  • Definition and scope creep: The bill's specific definition of "biomanufacturing" determines which companies qualify; overly broad definitions could allow unintended beneficiaries, while narrow ones may limit effectiveness
  • Long-term obligation: Tax credits can become permanent fiscal commitments that constrain future state budgets, even if the initial industry development goals are met

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.